Business Context and Reporting Period
This Form 6-K filing is submitted by Genmab A/S, a foreign private issuer, for the month of March 2026. The report, dated March 2, 2026, serves to incorporate by reference a Company Announcement (Exhibit 99.1) into the registrant's existing registration statements on Form S-8.
Key Financial Metrics
The provided filing text contains only cover page and signature information. It does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other specific financial metrics. The financial data is contained within the referenced Exhibit 99.1, which is not included in the input text.
Material Changes
No material changes versus the prior comparable period can be identified from the provided text, as no comparative financial data or operational updates are present in the filing excerpt.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details regarding unusual items. These elements are presumed to be located in the attached Company Announcement (Exhibit 99.1), the content of which is not available in the source text.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Company Announcement dated March 2, 2026) to obtain the specific news or financial data triggering this filing.
- Confirm the impact of the announcement on Genmab's current Form S-8 registration statements.
- Review the full text of the announcement for any new risks, strategic shifts, or financial updates not summarized in the cover page.